Gubra A/S (CPH:GUBRA)
Denmark · Delayed Price · Currency is DKK 352.20
+0.20 (0.06%)
May 27, 2026, 4:59 PM CET
Gubra Revenue
In the year 2025, Gubra had annual revenue of 2.64B DKK with 892.25% growth. Gubra had revenue of 144.68M in the half year ending December 31, 2025, with 40.21% growth.
Revenue
2.64B
Revenue Growth
+892.25%
P/S Ratio
2.18
Revenue / Employee
8.79M
Employees
300
Market Cap
5.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.64B | 2.37B | 892.25% |
| Dec 31, 2024 | 265.74M | 60.74M | 29.63% |
| Dec 31, 2023 | 205.01M | 5.62M | 2.82% |
| Dec 31, 2022 | 199.38M | -55.95M | -21.91% |
| Dec 31, 2021 | 255.33M | 83.03M | 48.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 327.80B |
| Coloplast | 28.05B |
| H. Lundbeck | 25.52B |
| Genmab | 25.29B |
| GN Store Nord | 16.60B |
| Zealand Pharma | 9.24B |
| ALK-Abelló | 6.56B |
| Embla Medical | 6.21B |
Gubra News
- 15 days ago - Gubra Earnings release: Q1 2026 - Filings
- 15 days ago - Gubra Slides: Q1 2026 - Filings
- 21 days ago - Gubra Earnings Call Transcript: Q1 2026 - Transcripts
- 21 days ago - Gubra Earnings release: Q1 2026 - Filings
- 21 days ago - Gubra Slides: Q1 2026 - Filings
- 6 weeks ago - Gubra Slides: Investor presentation - Filings
- 2 months ago - Gubra Slides: Investor presentation - Filings
- 3 months ago - Gubra Annual report: Q4 2025 - Filings